List of Excipients in API azilsartan kamedoxomil
✉ Email this page to a colleague
Excipients in NDA-approved (novel) drugs containing azilsartan kamedoxomil
| Company | Tradename | Ingredient | NDC | Excipient | Potential Generic Entry |
|---|---|---|---|---|---|
| Azurity Pharmaceuticals Inc | EDARBI | azilsartan kamedoxomil | 60631-040 | CELLULOSE, MICROCRYSTALLINE | |
| Azurity Pharmaceuticals Inc | EDARBI | azilsartan kamedoxomil | 60631-040 | CROSCARMELLOSE SODIUM | |
| Azurity Pharmaceuticals Inc | EDARBI | azilsartan kamedoxomil | 60631-040 | FUMARIC ACID | |
| Azurity Pharmaceuticals Inc | EDARBI | azilsartan kamedoxomil | 60631-040 | HYDROXYPROPYL CELLULOSE | |
| >Company | >Tradename | >Ingredient | >NDC | >Excipient | >Potential Generic Entry |
Detailed excipient profiles for azilsartan kamedoxomil
Excipient focus: ALCOHOL
azilsartan kamedoxomil drug variants containing ALCOHOL
| Company | Ingredient | NDC |
|---|---|---|
| Azurity Pharmaceuticals Inc (formerly Arbor Pharmaceuticals) | azilsartan kamedoxomil and chlorthalidone | 60631-412 |
| Pharma Packaging Solutions LLC dba Tjoapack LLC | azilsartan kamedoxomil and chlorthalidone | 75929-230 |
| >Company | >Ingredient | >NDC |
azilsartan kamedoxomil drug variants not containing ALCOHOL
| Company | Ingredient | NDC |
|---|---|---|
| Azurity Pharmaceuticals Inc | azilsartan kamedoxomil | 60631-040 |
| >Company | >Ingredient | >NDC |
Excipient focus: BUTYL ALCOHOL
azilsartan kamedoxomil drug variants containing BUTYL ALCOHOL
| Company | Ingredient | NDC |
|---|---|---|
| Azurity Pharmaceuticals Inc (formerly Arbor Pharmaceuticals) | azilsartan kamedoxomil and chlorthalidone | 60631-412 |
| Pharma Packaging Solutions LLC dba Tjoapack LLC | azilsartan kamedoxomil and chlorthalidone | 75929-230 |
| >Company | >Ingredient | >NDC |
azilsartan kamedoxomil drug variants not containing BUTYL ALCOHOL
| Company | Ingredient | NDC |
|---|---|---|
| Azurity Pharmaceuticals Inc | azilsartan kamedoxomil | 60631-040 |
| >Company | >Ingredient | >NDC |
Excipient focus: CELLULOSE, MICROCRYSTALLINE
azilsartan kamedoxomil drug variants containing CELLULOSE, MICROCRYSTALLINE
azilsartan kamedoxomil drug variants not containing CELLULOSE, MICROCRYSTALLINE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: CROSCARMELLOSE SODIUM
azilsartan kamedoxomil drug variants containing CROSCARMELLOSE SODIUM
| Company | Ingredient | NDC |
|---|---|---|
| Azurity Pharmaceuticals Inc | azilsartan kamedoxomil | 60631-040 |
| >Company | >Ingredient | >NDC |
azilsartan kamedoxomil drug variants not containing CROSCARMELLOSE SODIUM
| Company | Ingredient | NDC |
|---|---|---|
| Azurity Pharmaceuticals Inc (formerly Arbor Pharmaceuticals) | azilsartan kamedoxomil and chlorthalidone | 60631-412 |
| Pharma Packaging Solutions LLC dba Tjoapack LLC | azilsartan kamedoxomil and chlorthalidone | 75929-230 |
| >Company | >Ingredient | >NDC |
Excipient focus: CROSPOVIDONE
azilsartan kamedoxomil drug variants containing CROSPOVIDONE
| Company | Ingredient | NDC |
|---|---|---|
| Azurity Pharmaceuticals Inc (formerly Arbor Pharmaceuticals) | azilsartan kamedoxomil and chlorthalidone | 60631-412 |
| Pharma Packaging Solutions LLC dba Tjoapack LLC | azilsartan kamedoxomil and chlorthalidone | 75929-230 |
| >Company | >Ingredient | >NDC |
azilsartan kamedoxomil drug variants not containing CROSPOVIDONE
| Company | Ingredient | NDC |
|---|---|---|
| Azurity Pharmaceuticals Inc | azilsartan kamedoxomil | 60631-040 |
| >Company | >Ingredient | >NDC |
Excipient focus: FERRIC OXIDE RED
azilsartan kamedoxomil drug variants containing FERRIC OXIDE RED
| Company | Ingredient | NDC |
|---|---|---|
| Azurity Pharmaceuticals Inc (formerly Arbor Pharmaceuticals) | azilsartan kamedoxomil and chlorthalidone | 60631-412 |
| Pharma Packaging Solutions LLC dba Tjoapack LLC | azilsartan kamedoxomil and chlorthalidone | 75929-230 |
| >Company | >Ingredient | >NDC |
azilsartan kamedoxomil drug variants not containing FERRIC OXIDE RED
| Company | Ingredient | NDC |
|---|---|---|
| Azurity Pharmaceuticals Inc | azilsartan kamedoxomil | 60631-040 |
| >Company | >Ingredient | >NDC |
Excipient focus: FERROSOFERRIC OXIDE
azilsartan kamedoxomil drug variants containing FERROSOFERRIC OXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Azurity Pharmaceuticals Inc (formerly Arbor Pharmaceuticals) | azilsartan kamedoxomil and chlorthalidone | 60631-412 |
| Pharma Packaging Solutions LLC dba Tjoapack LLC | azilsartan kamedoxomil and chlorthalidone | 75929-230 |
| >Company | >Ingredient | >NDC |
azilsartan kamedoxomil drug variants not containing FERROSOFERRIC OXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Azurity Pharmaceuticals Inc | azilsartan kamedoxomil | 60631-040 |
| >Company | >Ingredient | >NDC |
Excipient focus: FUMARIC ACID
azilsartan kamedoxomil drug variants containing FUMARIC ACID
azilsartan kamedoxomil drug variants not containing FUMARIC ACID
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: HYDROXYPROPYL CELLULOSE
azilsartan kamedoxomil drug variants containing HYDROXYPROPYL CELLULOSE
azilsartan kamedoxomil drug variants not containing HYDROXYPROPYL CELLULOSE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: HYPROMELLOSE
azilsartan kamedoxomil drug variants containing HYPROMELLOSE
| Company | Ingredient | NDC |
|---|---|---|
| Azurity Pharmaceuticals Inc (formerly Arbor Pharmaceuticals) | azilsartan kamedoxomil and chlorthalidone | 60631-412 |
| Pharma Packaging Solutions LLC dba Tjoapack LLC | azilsartan kamedoxomil and chlorthalidone | 75929-230 |
| >Company | >Ingredient | >NDC |
azilsartan kamedoxomil drug variants not containing HYPROMELLOSE
| Company | Ingredient | NDC |
|---|---|---|
| Azurity Pharmaceuticals Inc | azilsartan kamedoxomil | 60631-040 |
| >Company | >Ingredient | >NDC |
Excipient focus: MAGNESIUM STEARATE
azilsartan kamedoxomil drug variants containing MAGNESIUM STEARATE
azilsartan kamedoxomil drug variants not containing MAGNESIUM STEARATE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: MANNITOL
azilsartan kamedoxomil drug variants containing MANNITOL
azilsartan kamedoxomil drug variants not containing MANNITOL
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: POLYETHYLENE GLYCOL 8000
azilsartan kamedoxomil drug variants containing POLYETHYLENE GLYCOL 8000
| Company | Ingredient | NDC |
|---|---|---|
| Azurity Pharmaceuticals Inc (formerly Arbor Pharmaceuticals) | azilsartan kamedoxomil and chlorthalidone | 60631-412 |
| Pharma Packaging Solutions LLC dba Tjoapack LLC | azilsartan kamedoxomil and chlorthalidone | 75929-230 |
| >Company | >Ingredient | >NDC |
azilsartan kamedoxomil drug variants not containing POLYETHYLENE GLYCOL 8000
| Company | Ingredient | NDC |
|---|---|---|
| Azurity Pharmaceuticals Inc | azilsartan kamedoxomil | 60631-040 |
| >Company | >Ingredient | >NDC |
Excipient focus: SHELLAC
azilsartan kamedoxomil drug variants containing SHELLAC
| Company | Ingredient | NDC |
|---|---|---|
| Azurity Pharmaceuticals Inc (formerly Arbor Pharmaceuticals) | azilsartan kamedoxomil and chlorthalidone | 60631-412 |
| Pharma Packaging Solutions LLC dba Tjoapack LLC | azilsartan kamedoxomil and chlorthalidone | 75929-230 |
| >Company | >Ingredient | >NDC |
azilsartan kamedoxomil drug variants not containing SHELLAC
| Company | Ingredient | NDC |
|---|---|---|
| Azurity Pharmaceuticals Inc | azilsartan kamedoxomil | 60631-040 |
| >Company | >Ingredient | >NDC |
Excipient focus: SODIUM HYDROXIDE
azilsartan kamedoxomil drug variants containing SODIUM HYDROXIDE
azilsartan kamedoxomil drug variants not containing SODIUM HYDROXIDE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: TALC
azilsartan kamedoxomil drug variants containing TALC
| Company | Ingredient | NDC |
|---|---|---|
| Azurity Pharmaceuticals Inc (formerly Arbor Pharmaceuticals) | azilsartan kamedoxomil and chlorthalidone | 60631-412 |
| Pharma Packaging Solutions LLC dba Tjoapack LLC | azilsartan kamedoxomil and chlorthalidone | 75929-230 |
| >Company | >Ingredient | >NDC |
azilsartan kamedoxomil drug variants not containing TALC
| Company | Ingredient | NDC |
|---|---|---|
| Azurity Pharmaceuticals Inc | azilsartan kamedoxomil | 60631-040 |
| >Company | >Ingredient | >NDC |
Excipient focus: TITANIUM DIOXIDE
azilsartan kamedoxomil drug variants containing TITANIUM DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Azurity Pharmaceuticals Inc (formerly Arbor Pharmaceuticals) | azilsartan kamedoxomil and chlorthalidone | 60631-412 |
| Pharma Packaging Solutions LLC dba Tjoapack LLC | azilsartan kamedoxomil and chlorthalidone | 75929-230 |
| >Company | >Ingredient | >NDC |
azilsartan kamedoxomil drug variants not containing TITANIUM DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Azurity Pharmaceuticals Inc | azilsartan kamedoxomil | 60631-040 |
| >Company | >Ingredient | >NDC |
Excipient focus: WATER
azilsartan kamedoxomil drug variants containing WATER
| Company | Ingredient | NDC |
|---|---|---|
| Azurity Pharmaceuticals Inc (formerly Arbor Pharmaceuticals) | azilsartan kamedoxomil and chlorthalidone | 60631-412 |
| Pharma Packaging Solutions LLC dba Tjoapack LLC | azilsartan kamedoxomil and chlorthalidone | 75929-230 |
| >Company | >Ingredient | >NDC |
azilsartan kamedoxomil drug variants not containing WATER
| Company | Ingredient | NDC |
|---|---|---|
| Azurity Pharmaceuticals Inc | azilsartan kamedoxomil | 60631-040 |
| >Company | >Ingredient | >NDC |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
© Copyright 2002-2025 thinkBiotech LLC
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2025 - 2026
NCE-1 Patent Challenge Dates 2025 - 2026
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2025 - 2026
NCE-1 Patent Challenge Dates 2025 - 2026
Preferred Citation:
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2025, www.DrugPatentWatch.com.
See Primary Research Papers Citing DrugPatentWatch
Links